Literature DB >> 18949472

Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel (1)H-MRS at 1.5 T.

Mikhail F Chernov1, Yoshihiro Muragaki, Takashi Maruyama, Yuko Ono, Masao Usukura, Shigetoshi Yoshida, Ryoichi Nakamura, Hiroshi Iseki, Osami Kubo, Tomokatsu Hori, Kintomo Takakura.   

Abstract

INTRODUCTION: The present study was done for evaluation of the possible influence of the oral administration of choline on metabolic characteristics of gliomas detected with proton magnetic resonance spectroscopy ((1)H-MRS).
MATERIALS AND METHODS: Thirty patients (22 men and eight women; mean age 38 +/- 15 years) with suspicious intracranial gliomas underwent single-voxel long-echo (TR 2,000 ms, TE 136 ms, 128-256 acquisitions) (1)H-MRS of the tumor, peritumoral brain tissue, and distant normal-appearing white matter before and several hours (median, 3 h; range, 1.2-3.7 h) after ingestion of choline with prescribed dose of 50 mg/kg (median actual dose, 52 mg/kg; range, 48-78 mg/kg). Investigations were done using 1.5 T clinical magnetic resonance imager. The volume of the rectangular (1)H-MRS voxel was either 3.4 or 8 cm(3). At the time of both spectroscopic examinations, similar voxels' positioning and size and technical parameters of (1)H-MRS were used. Surgery was done in 27 patients within 1 to 68 days thereafter. In all cases, more than 80% resection of the neoplasm was attained.
RESULTS: There were 12 low-grade gliomas and 15 high-grade gliomas. MIB-1 index varied from 0% to 51.7% (median, 13.8%). Statistical analysis did not disclose significant differences of any investigated metabolic parameter of the tumor, peritumoral brain tissue and distant normal-appearing white matter between two spectroscopic examinations.
CONCLUSION: Single-voxel (1)H-MRS at 1.5 T could not detect significant changes of the metabolic characteristics of gliomas, peritumoral brain tissue, and distant normal-appearing white matter after oral administration of choline.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18949472     DOI: 10.1007/s00234-008-0471-x

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  19 in total

Review 1.  Proton MR spectroscopy of the brain.

Authors:  S D Rand; R Prost; S J Li
Journal:  Neuroimaging Clin N Am       Date:  1999-05       Impact factor: 2.264

Review 2.  The clinical value of proton magnetic resonance spectroscopy in adult brain tumours.

Authors:  N A Sibtain; F A Howe; D E Saunders
Journal:  Clin Radiol       Date:  2007-02       Impact factor: 2.350

3.  PET imaging of brain tumor with [methyl-11C]choline.

Authors:  T Hara; N Kosaka; N Shinoura; T Kondo
Journal:  J Nucl Med       Date:  1997-06       Impact factor: 10.057

Review 4.  Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.

Authors:  Tracy Richmond McKnight
Journal:  Semin Oncol       Date:  2004-10       Impact factor: 4.929

5.  Serial proton magnetic resonance spectroscopy in lesions of Balò concentric sclerosis.

Authors:  C J Chen
Journal:  J Comput Assist Tomogr       Date:  2001 Sep-Oct       Impact factor: 1.826

6.  Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain.

Authors:  J Tan; S Bluml; T Hoang; D Dubowitz; G Mevenkamp; B Ross
Journal:  Magn Reson Med       Date:  1998-06       Impact factor: 4.668

7.  Oral choline increases choline metabolites in human brain.

Authors:  Suzann M Babb; Yong Ke; Nicholas Lange; Marc J Kaufman; Perry F Renshaw; Bruce M Cohen
Journal:  Psychiatry Res       Date:  2004-01-15       Impact factor: 3.222

Review 8.  (1)H MR spectroscopy of inflammation, infection and ischemia of the brain.

Authors:  Irina Mader; Sebastian Rauer; Peter Gall; Uwe Klose
Journal:  Eur J Radiol       Date:  2008-04-14       Impact factor: 3.528

9.  Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study.

Authors:  A L Stoll; P F Renshaw; E De Micheli; R Wurtman; S S Pillay; B M Cohen
Journal:  Biol Psychiatry       Date:  1995-02-01       Impact factor: 13.382

10.  Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.

Authors:  Sandi A Kwee; Jehoon P Ko; Caroline S Jiang; Michael R Watters; Marc N Coel
Journal:  Radiology       Date:  2007-06-20       Impact factor: 11.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.